tirzepatide reconstitute Weightloss Peptide, Patient Information Leaflets, Dosage, Reconstitution, Medspa Handout Templates, Edit in Canva Terzapatide Reconstitute 15 Mg |

FDA Registration No.: FR-4000015185994

Patients losing substantial weight quickly may not maintain sufficient intake of micronutrients, including iron, particularly if they are not receiving appropriate nutritional counselling

At Hormone Replacement Therapy LA, we are committed to supporting your weight loss journey with expertise and personalized care

Pregnancy, Breastfeeding, and Fertility Considerations GLP-1 medications are not approved for use during pregnancy, and most clinical guidelines recommend discontinuation at least 2-3 months before attempting conception

Quotes represent the opinions of our medical experts

Genetic Predispositions: Certain genetic factors may predispose individuals to a higher risk of blood clots when taking Wegovy